AceReport Image
SPINE
Gabapentinoids, topiramate do not demonstrate significant effect on pain and disability in LBP
Verified
This report has been verified by one or more authors of the original publication.
CMAJ. 2018 Jul 3;190(26):E786-E793. doi: 10.1503/cmaj.171333

Nine randomized controlled trials were included in the meta-analysis and systematic review, which was conducted to analyze the effects of anticonvulsants - including gabapentinoids and topiramate - in patients with either nonspecific low back pain or lumbar radicular pain secondary to spinal stenosis. Results on gabapentinoids demonstrated no significant differences relative to placebo on either pain or disability measures in patients with either pathology, coupled with a significant increase in the rate of adverse events. Results on topiramate demonstrated a statistically significant effect on immediate pain relative to placebo in patients with nonspecific low back pain, though differences thereafter were not significant. Additionally, no significant effect of topiramate compared to placebo was observed among patients with lumbar radicular pain.

Unlock the full ACE Report

You have access to {0} free articles per month.
Click below to unlock and view this {1}
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
{0} of {1} free articles

Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.

Upgrade Now
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade Account
Upgrade
Search
Close Search Window
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. Gabapentinoids, topiramate do not demonstrate significant effect on pain and disability in LBP. ACE Report. 2018;8(8):13. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report